This month, 30 shareholders of listed companies increased their holdings, with a total amount of 170 million yuan.
On April 25, the central bank announced that in order to improve the ability of financial institutions to use foreign exchange funds, the central bank decided to reduce the foreign exchange deposit reserve ratio of financial institutions by 1 percentage point from May 15, 2022, that is, the foreign exchange deposit reserve ratio was reduced from the current 9% to 8%
According to relevant regulations, the foreign exchange deposit reserve refers to the deposit that financial institutions deposit a certain proportion of their foreign exchange deposits with the central bank in accordance with regulations, and the foreign exchange deposit reserve ratio refers to the ratio between the foreign exchange deposit reserve deposited by financial institutions with the central bank and their foreign exchange deposits. Historically, this is the first time that the central bank has lowered the foreign exchange deposit reserve ratio. It has been raised many times before. It has been raised twice only in 2021, from 5% to 9%.
The reduction of foreign exchange deposit reserve ratio may be related to the depreciation of RMB exchange rate. Recently, there have been signs of rapid depreciation of the RMB exchange rate, with a cumulative depreciation rate of 2.8% in the past week. The previous two increases in the foreign exchange reserve ratio occurred during the rapid appreciation of the RMB, which had a significant effect. This time, the central bank quickly lowered the RMB exchange rate, or intended to curb the depreciation.
Cinda Securities believes that the reduction of the foreign exchange reserve ratio will release some foreign exchange liquidity, increase the supply of US dollars in the foreign exchange market, and improve the willingness and ability of financial institutions to sell foreign exchange, so as to alleviate the pressure of RMB devaluation. This adjustment will release foreign exchange liquidity of about US $10 billion.
As soon as the news was announced, domestic and foreign RMB exchange rate declines narrowed, the rise of the US dollar against the onshore RMB narrowed from 1.98% to 1.14%, and the rise of the US dollar against the offshore RMB narrowed from 1.23% to 0.01%. The upward trend since this month has been significantly curbed.
the general office of the State Council issued a document to promote the recovery of consumption
Last night, the general office of the State Council issued the opinions on further releasing consumption potential and promoting sustainable recovery of consumption, and issued a series of measures. The opinions stressed that focusing on the main body of the insurance market, we should strengthen the rescue of enterprises, guide financial institutions to optimize credit management, and provide financing support to industrial enterprises seriously affected by the epidemic.
The Opinions also mentioned that we should improve the government’s green procurement standards and strengthen the procurement of green and low-carbon products. Regions with conditions are encouraged to give appropriate subsidies or loan interest discounts to the consumption of green smart appliances, green building materials and energy-saving products. We will study further reducing import tariffs on high-quality consumer goods that are closely related to people’s lives and have strong demand.
Statistics show that a total of 28 shares in the home appliance sector have announced the first quarter performance forecast or performance express, mainly in advance. From the median year-on-year increase of net profit, 19 shares have been increased in advance Changhong Huayi Compressor Co.Ltd(000404) , Jiangsu Xiuqiang Glasswork Co.Ltd(300160) , Guangdong Pak Corporation Co.Ltd(300625) is expected to be among the top, with 369.52%, 217.5% and 156.52% respectively
A total of 26 shares in the building materials sector announced the performance forecast or performance express in the first quarter. Most of them were affected by the rise in the price of upstream raw materials or the rise in costs. The profit in the first quarter declined, and only 9 shares had a performance advance Shandong Yabo Technology Co.Ltd(002323) , China Jushi Co.Ltd(600176) , Goody Science & Technology Co.Ltd(002694) are expected to increase by 183.8%, 72.68% and 28.37% respectively.
4 listed companies’ executives increased their holdings by more than ten million yuan
At the time of market correction, many executives of listed companies will choose to reduce their holdings. At the same time, some executives of listed companies, out of recognition of the company’s value and confidence in the company’s future development, chose to increase their shares in the case of market fluctuations to boost market sentiment.
According to the statistics of securities times · data treasure, 30 shareholders of listed companies have increased their holdings this month, with a total amount of 170 million yuan, of which Jinyu Bio-Technology Co.Ltd(600201) , Shandong Hualu-Hengsheng Chemical Co.Ltd(600426) , Sinoma International Engineering Co.Ltd(600970) , Zhejiang Crystal-Optech Co.Ltd(002273) increased their holdings by more than 10 million yuan.
Jinyu Bio-Technology Co.Ltd(600201) was increased by two senior executives yesterday, with a total increase of 556402 million yuan. The company recently disclosed its annual report, realizing an operating revenue of 1.776 billion yuan, a year-on-year increase of 12.29%, and a net profit attributable to shareholders of listed companies of 382 million yuan, a slight decrease of 5.89% over the same period. After the increase of senior executives’ holdings, the company disclosed last night that the subsidiary has obtained the approval document number of veterinary drug products for the production of Brucella gene deletion live vaccine. So far, the cumulative R & D investment of the product is about 5.98 million yuan.
Recently, most of the stocks increased were in the correction stage, but some stocks still rose against the market. The cumulative rise and fall of this month was positive, including China Resources Double-Crane Pharmaceutical Co.Ltd(600062) , Anhui Construction Engineering Group Corporation Limited(600502) , Lingda Group Co.Ltd(300125) , of which China Resources Double-Crane Pharmaceutical Co.Ltd(600062) yesterday’s rise limit, which has increased by 46.29% this month.
China Resources Double-Crane Pharmaceutical Co.Ltd(600062) recently released an announcement of abnormal stock trading fluctuations, saying that recently, the market rumor said that “the covid-19 oral drug azvudine of Henan real biology is about to be blinded, and China Resources Double-Crane Pharmaceutical Co.Ltd(600062) will sign an agency production and sales agreement with Henan real biology”. So far, the company has not reached relevant agreements with Henan real life. The day after the announcement, China Resources Double-Crane Pharmaceutical Co.Ltd(600062) quickly fell to the limit, and then continued to rise.
